Physician profile
Ankit D Patel
NPI 1417213539
$5,178.81
in general payments reported to CMS, 2019-2025
10 companies · $641 in 2025
The $641 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,898 · 2020: $203 · 2021: $461 · 2022: $273 · 2023: $866 · 2024: $837 · 2025: $641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,343.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,044.63 | 2019-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter, G4 Rf Generator |
| Medtronic, INC. | $1,547.94 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Spr Therapeutics, INC | $161.34 | 2022-2024 | Sprint Pns System |
| Nevro Corp. | $147.29 | 2021-2023 | Senza |
| Merck Sharp & Dohme LLC | $123.31 | 2021-2024 | Bridion |
| Pacira Pharmaceuticals Incorporated | $78.83 | 2021-2024 | Iovera, Exparel |
| Medtronic USA, INC. | $31.44 | 2019-2020 | |
| Chiesi USA, INC. | $17.23 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $15.72 | 2024 | |
| Masimo Corporation | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.